297 related articles for article (PubMed ID: 22575755)
1. PHEA-graft-polybutylmethacrylate copolymer microparticles for delivery of hydrophobic drugs.
Licciardi M; Di Stefano M; Craparo EF; Amato G; Fontana G; Cavallaro G; Giammona G
Int J Pharm; 2012 Aug; 433(1-2):16-24. PubMed ID: 22575755
[TBL] [Abstract][Full Text] [Related]
2. Phospholipid-polyaspartamide micelles for pulmonary delivery of corticosteroids.
Craparo EF; Teresi G; Bondi' ML; Licciardi M; Cavallaro G
Int J Pharm; 2011 Mar; 406(1-2):135-44. PubMed ID: 21185363
[TBL] [Abstract][Full Text] [Related]
3. PHEA-PLA biocompatible nanoparticles by technique of solvent evaporation from multiple emulsions.
Cavallaro G; Craparo EF; Sardo C; Lamberti G; Barba AA; Dalmoro A
Int J Pharm; 2015 Nov; 495(2):719-27. PubMed ID: 26410757
[TBL] [Abstract][Full Text] [Related]
4. Drug release from alpha,beta-poly(N-2-hydroxyethyl)-DL-aspartamide-based microparticles.
Pitarresi G; Pierro P; Giammona G; Iemma F; Muzzalupo R; Picci N
Biomaterials; 2004 Aug; 25(18):4333-43. PubMed ID: 15046924
[TBL] [Abstract][Full Text] [Related]
5. Polymeric drug delivery micelle-like nanocarriers for pulmonary administration of beclomethasone dipropionate.
Triolo D; Craparo EF; Porsio B; Fiorica C; Giammona G; Cavallaro G
Colloids Surf B Biointerfaces; 2017 Mar; 151():206-214. PubMed ID: 28013164
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated and pegylated polyaspartamide derivatives to increase solubility and efficacy of Flutamide.
Piccionello AP; Pitarresi G; Pace A; Triolo D; Picone P; Buscemi S; Giammona G
J Drug Target; 2012 Jun; 20(5):433-44. PubMed ID: 22533704
[TBL] [Abstract][Full Text] [Related]
7. Realization of polyaspartamide-based nanoparticles and in vivo lung biodistribution evaluation of a loaded glucocorticoid after aerosolization in mice.
Craparo EF; Di Gioia S; Trapani A; Cellamare S; Belgiovine G; Mandracchia D; Giammona G; Cavallaro G; Conese M
Int J Pharm; 2016 Aug; 510(1):263-70. PubMed ID: 27326484
[TBL] [Abstract][Full Text] [Related]
8. Amphiphilic polyaspartamide copolymer-based micelles for rivastigmine delivery to neuronal cells.
Scialabba C; Rocco F; Licciardi M; Pitarresi G; Ceruti M; Giammona G
Drug Deliv; 2012 Aug; 19(6):307-16. PubMed ID: 22931301
[TBL] [Abstract][Full Text] [Related]
9. Nanoaggregates based on new poly-hydroxyethyl-aspartamide copolymers for oral insulin absorption.
Licciardi M; Pitarresi G; Cavallaro G; Giammona G
Mol Pharm; 2013 May; 10(5):1644-54. PubMed ID: 23331253
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticles of a polyaspartamide-based brush copolymer for modified release of sorafenib: In vitro and in vivo evaluation.
Cervello M; Pitarresi G; Volpe AB; Porsio B; Balasus D; Emma MR; Azzolina A; Puleio R; Loria GR; Puleo S; Giammona G
J Control Release; 2017 Nov; 266():47-56. PubMed ID: 28917533
[TBL] [Abstract][Full Text] [Related]
11. Polymeric nanocarriers for magnetic targeted drug delivery: preparation, characterization, and in vitro and in vivo evaluation.
Licciardi M; Scialabba C; Fiorica C; Cavallaro G; Cassata G; Giammona G
Mol Pharm; 2013 Dec; 10(12):4397-407. PubMed ID: 24168360
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of burst release from pH-responsive polymeric microparticles.
Rizi K; Green RJ; Khutoryanskaya O; Donaldson M; Williams AC
J Pharm Pharmacol; 2011 Sep; 63(9):1141-55. PubMed ID: 21827486
[TBL] [Abstract][Full Text] [Related]
13. Study on drug release behaviors of poly-alpha,beta-[n-(2-hydroxyethyl)-L-aspartamide]-g-poly(epsilon-caprolactone) nano- and microparticles.
Miao ZM; Cheng SX; Zhang XZ; Zhuo RX
Biomacromolecules; 2006 Jun; 7(6):2020-6. PubMed ID: 16768428
[TBL] [Abstract][Full Text] [Related]
14. PHEA-graft-polymethacrylate supramolecular aggregates for protein oral delivery.
Licciardi M; Pasut G; Amato G; Scialabba C; Mero A; Montopoli M; Cavallaro G; Schiavon O; Giammona G
Eur J Pharm Biopharm; 2013 May; 84(1):21-8. PubMed ID: 23275110
[TBL] [Abstract][Full Text] [Related]
15. Functionalization of magnetic nanoparticles with dendritic-linear-brush-like triblock copolymers and their drug release properties.
He X; Wu X; Cai X; Lin S; Xie M; Zhu X; Yan D
Langmuir; 2012 Aug; 28(32):11929-38. PubMed ID: 22799877
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and in vitro drug release study of microsphere drug delivery systems based on amphiphilic poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) graft copolymers.
Zhou YX; Li SL; Fu HL; Cheng SX; Zhang XZ; Zhuo RX
Colloids Surf B Biointerfaces; 2008 Feb; 61(2):164-9. PubMed ID: 17851053
[TBL] [Abstract][Full Text] [Related]
17. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
Sajeesh S; Sharma CP
Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) biodegradable copolymers as drug carriers.
Peng T; Cheng SX; Zhuo RX
J Biomed Mater Res A; 2006 Jan; 76(1):163-73. PubMed ID: 16258962
[TBL] [Abstract][Full Text] [Related]
19. The robustness and flexibility of an emulsion solvent evaporation method to prepare pH-responsive microparticles.
Nilkumhang S; Basit AW
Int J Pharm; 2009 Jul; 377(1-2):135-41. PubMed ID: 19515519
[TBL] [Abstract][Full Text] [Related]
20. Preparation and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(D,L-lactic-co-glycolic acid) microspheres using a double emulsion/solvent evaporation technique.
Karal-Yılmaz O; Serhatlı M; Baysal K; Baysal BM
J Microencapsul; 2011; 28(1):46-54. PubMed ID: 21171816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
